Research projects
Clinical Studies
Deep Brain Stimulation
The idea of this study is to make use of few remaining intact fibres of the spinal cord by electrical stimulation of a certain region in the brain in order to activate the local control centers of the spinal cord by a multiple amplified signal.
Nogo Antibody Study
Nogo is a protein that is found only in the central nervous system, where it prevents nerve regeneration. Conversely, antibodies to Nogo encourage damaged nerves to grow again.
More information
EMSCI
The aim of this study is to provide the required clinical basis for the implementation of novel interventional therapies.
TASCI study

Spinal cord injuries lead to bladder dysfunction, which can often severely impair quality of life and endanger kidney function. The TASCI study is investigating whether electrical stimulation therapy, known as “neuromodulation,” can prevent the development of dangerous bladder dysfunctions.
Completed Clinical Trials
Neural Stem Cell Trial
In addition to assessing safety, the trial did measure defined clinical endpoints, such as changes in sensation, motor, and bowel/bladder function. All patients received HuCNS-SC cells through direct transplantation into the spinal cord, and were temporarily immunosuppressed.
STIMO
Electrical epidural stimulations (EES) of the spinal cord are clinically tested in order to improve standing and walking ability. The study is currently being carried out in collaboration between Lausanne University Hospital and the Spinal Cord Injury Centre at Balgrist University Hospital.
Neuro rehabilitation
Upper extremities
Activity monitoring of the upper extremities during rehabilitation after spinal cord injuries (SCI).
Lower Limbs
A mobile system for interactive unsupervised lower limb rehabilitation training with virtual reality, based on a further development of the existing stationary
Movement Laboratory
New findings of the basic pathophysiological mechanisms underlying walking impairments in neurological disorders, thus, improving diagnosis, treatment, stratification and outcome prediction of patients.
Inclusive Protocols
The aim of this project ist the development of accurate inclusion/exclusion criteria for SCI trial participants, whether they be complete (ASIA Impairment Scale A or AIS-A) or incomplete, (AIS-B to AIS-D).
Neuro imaging
Relationship between changes in spinal cord and brain morphometry to clinical recovery following acute spinal cord injury.
Neurourology
Sacral neuromodulation
Sacral neuromodulation for neurogenic lower urinary tract dysfunction: A randomized, placebo- controlled, double blind clinical trial.

The bladder and the brain - fMRI study
Supraspinal control of lower urinary tract function in patients with neurogenic and non-neurogenic bladder dysfunction.

LUT and EEG
Evaluation of new approaches in the treatment and neurophysiological assessment of healthy and impaired human lower urinary tract function.
Neurophysiology
Sensory evaluation

Supra- and spinal pain control
Changes within the sensory system following spinal cord injury (SCI) not only affect the individual specific sensory modalities (proprio-, noci-, mechano-, enteroception) but also physiological sensori-sensory interactions across the spinal and supra-spinal system.

CHEPs in lower limbs and small fibre neuropathy
Small fiber integrity can be assessed with CHEPs but recording potentials from the lower extremities has been considered rather difficult and poorly reproducible. Therefore, we aimed to investigate the feasibility of CHEPs from lower extremities deploying our increased baseline stimulation protocol.

Cold-evoked potentials
Cold allodynia, a symptom frequently encountered in individuals with SCI suffering from neuropathic pain, has so far escaped proper appreciation, owing to the absence of an objective method in order to functionally dissect the underlying spinal pathways. Thus, a new assessment paradigm to record cold-evoked potentials has been piloted.
KFSP Pain
The overall objective of this CRPP is to dissect the impact of peripheral, spinal and supra-spinal processes that cause sensitization and modulation in order to provide a framework for mechanistically founded therapies across disease entities.